ASIDE Endocrinology

Original Article

• Efficacy and Safety of Lower- versus Higher-Dose Baxdrostat in Adults with Resistant or Uncontrolled Hypertension, Including a CKD-Enriched Population: An Indirect Subgroup Comparison from Placebo-Controlled Trials — A Systematic Review and Meta-Analysis with GRADE Assessment

  Ahmed L Youseif, Mohamed Eldahrawy, Abdallah Al Ghnaimat, Alaa Ashraf Mohamed, Mohamed Nabil Hamouda, Karim A Khalil, Ahmed F Younis

  1-9

  • PDF
  • Supplementary File

• Trends in Mortality Co‑Reporting Heart Failure and Metabolic Syndrome–Related Conditions Among U.S. Adults Aged ≥25 Years, 1999–2023: A CDC WONDER Analysis

  Zubair Ahmed, Falak Naz, Kayode Ogunniyi, Kanchan Chaudhary, Shaista Ali, FNU Barkha, Muhammad Rizwan, Salar Shahzad, Abdul Rauf, FNU Asadullah, FNU Saadullah, Muhammad Awais, Laksh Kumar Ahuja

  10-19

  • PDF